7212084/Beijing Natural Science Foundation[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2022	2
2024	1
2025	0

Page 1

Pneumonic-type lung adenocarcinoma with KRAS G12V mutation and sustained response to Afatinib.

Zhao J, Xu J, Qiu T, Wang J, Wang Z. Zhao J, et al. Pneumonia (Nathan). 2024 Apr 25;16(1):7. doi: 10.1186/s41479-024-00128-w. Pneumonia (Nathan). 2024. PMID: 38659041 Free PMC article.

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.

Dong Y, Zhao L, Duan J, Bai H, Chen D, Li S, Yu Y, Xiao M, Zhang Q, Duan Q, Sun T, Qi C, Wang J, Wang Z. Dong Y, et al. Cell Prolif. 2022 Sep;55(9):e13283. doi: 10.1111/cpr.13283. Epub 2022 Jul 10. Cell Prolif. 2022. PMID: 35811392 Free PMC article.

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer.

Feng Y, Liu Y, Yuan M, Dong G, Zhang H, Zhang T, Chang L, Xia X, Li L, Zhu H, Xing P, Wang H, Shi Y, Wang Z, Hu X. Feng Y, et al. Cancer Res Treat. 2022 Jul;54(3):753-766. doi: 10.4143/crt.2021.905. Epub 2021 Oct 5. Cancer Res Treat. 2022. PMID: 34645133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year